Prevention efforts focused on youth reduce prescription abuse into adulthood

Middle school students from small towns and rural communities who received any of three community-based prevention programs were less likely to abuse prescription medications in late adolescence and young adulthood. The research, published today in the American Journal of Public Health, was funded by the National Institute on Drug Abuse (NIDA), the National Institute on Alcohol Abuse and Alcoholism, and the National Institute of Mental Health, all components of the National Institutes of Health.

"Prescription medications are beneficial when used as prescribed to treat pain, anxiety, or ADHD," said NIDA Director Dr. Nora D. Volkow. "However, their abuse can have serious consequences, including addiction or even death from overdose. We are especially concerned about prescription among teens, who are developmentally at an increased risk for addiction."

Prescription drug abuse—taking a medication without a prescription or in a way (higher dose, snorted) or for reasons other than prescribed (to get high)—has become one of the most serious public health concerns in the United States. According to the 2012 Monitoring the Future survey of U.S. teen substance use, prescription and over-the-counter medications were among the top substances abused by 12th graders in the past year. In 2011, about 1.7 million people 12-25 years old, or more than 4,500 young people per day, abused a prescription drug for the first time, according to the latest National Survey on Drug Use and Health.

The article, by scientists at Iowa State University, Ames, and Penn State, University Park, presents the combined research results of three randomized controlled trials of preventive interventions – termed "universal" because they target all youth regardless of risk for future substance abuse. All three studies involved rural or small-town students in grades six or seven, who were randomly assigned to a control condition (receiving no prevention intervention) or to a family-focused intervention alone or in combination with a school-based intervention:

  • Study 1, begun in 1993, tested a family-focused intervention alone (22 schools).
  • Study 2, begun in 1997, tested a combined family-focused intervention and a school-based life skills training program (24 schools).
  • Study 3, begun in 2002, tested a delivery system for a family-focused intervention and one of three school-based interventions selected from a menu (28 schools).

All of these interventions addressed general risk and protective factors for substance abuse rather than specifically targeting prescription drug abuse. In follow-up questionnaires and telephone interviews completed at 17-25 years of age, students across the three studies showed reductions in risk—ranging from about 20 percent to as much as 65 percent—for prescription drug and opioid abuse, compared to students in the control groups. Importantly, the interventions used had previously been shown to reduce the likelihood of other substance use or other problem behaviors.

"We could find no other randomized, controlled studies where brief community-based preventive interventions conducted during middle school were associated with long-term reductions in prescription drug abuse—six to 14 years after initial program implementation," said Dr. Richard Spoth, from the Partnerships in Prevention Science Institute at Iowa State University and first author on the study. "The intervention effects were comparable or even stronger for participants who had started misusing substances prior to the middle school interventions, suggesting that these programs also can be successful in higher-risk groups."

More information: ajph.aphapublications.org/toc/ajph/0/0

add to favorites email to friend print save as pdf

Related Stories

Suboxone is most effective in treating painkiller addiction

Nov 07, 2011

Individuals addicted to prescription painkillers are more likely to succeed in treatment with the aid of the medication buprenorphine-naloxone (Suboxone), report McLean Hospital and Harvard Medical School researchers in today's ...

Recommended for you

Mirabegron for overactive bladder: Added benefit not proven

13 hours ago

Mirabegron (trade name: Betmiga) has been approved since December 2012 for the treatment of adults with overactive bladder. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products ...

Novartis Japan admits concealing drug side effects

Sep 01, 2014

The Japanese unit of Swiss pharma giant Novartis has admitted it did not report more than 2,500 cases of serious side effects in patients using its leukaemia and other cancer drugs, reportedly including some fatalities.

Most US babies get their vaccines, CDC says

Aug 28, 2014

(HealthDay)—The vast majority of American babies are getting the vaccines they need to protect them from serious illnesses, federal health officials said Thursday.

User comments